|
|
Volumn 353, Issue 9149, 1999, Pages 257-258
|
|
Outstanding issues in use of disease-modifying agents in rheumatoid arthritis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
AURANOFIN;
CORTICOSTEROID;
GOLD;
HYDROXYCHLOROQUINE;
LEFLUNOMIDE;
METHOTREXATE;
MINOCYCLINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PENICILLAMINE;
SALAZOSULFAPYRIDINE;
AGRANULOCYTOSIS;
ALOPECIA;
CLINICAL TRIAL;
DRUG COST;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SHORT SURVEY;
TREATMENT OUTCOME;
|
|
EID: 0033059541
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)74938-2 Document Type: Note |
|
Times cited : (10)
|
|
References (16)
|
